CLINICAL AND PATHOPHYSIOLOGICAL ASPECTS OF VIRAL HEPATITI

Authors

  • Dr. Razial Kamal Independent researcher of medical centre in Bangladesh

DOI:

https://doi.org/10.55640/

Keywords:

viral hepatitis, hepatitis B, hepatitis C, hepatocellular carcinoma, antiviral therapy

Abstract

Viral hepatitis represents a major global health burden, affecting millions of people worldwide and causing significant morbidity and mortality. The disease is primarily caused by hepatotropic viruses (hepatitis A, B, C, D, and E), each with distinct transmission routes, clinical manifestations, and long-term outcomes. Chronic viral hepatitis, particularly types B and C, is strongly associated with cirrhosis and hepatocellular carcinoma, making it a critical focus for prevention and treatment. This article reviews the pathophysiological mechanisms, clinical features, and pharmacological management of viral hepatitis, highlighting current challenges and advances in antiviral therapy.

Downloads

Download data is not yet available.

References

1.World Health Organization. (2022). Global progress report on HIV, viral hepatitis and sexually transmitted infections. WHO Press.

2.Terrault, N. A., Lok, A. S., McMahon, B. J., Chang, K. M., Hwang, J. P., et al. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 guidance. Hepatology, 67(4), 1560–1599.

3.Pawlotsky, J. M. (2016). Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens. Gastroenterology, 151(1), 70–86.

4.Ringehan, M., McKeating, J. A., & Protzer, U. (2017). Viral hepatitis and liver cancer. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1732), 20160274.

5.Polaris Observatory Collaborators. (2022). Global prevalence and genotype distribution of hepatitis C virus infection. The Lancet Gastroenterology & Hepatology, 7(8), 724–735.

Downloads

Published

2025-12-30

Issue

Vol. 4 No. 11 (2025): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

CLINICAL AND PATHOPHYSIOLOGICAL ASPECTS OF VIRAL HEPATITI. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(11), 3620-3622. https://doi.org/10.55640/

Similar Articles

1-10 of 260

You may also start an advanced similarity search for this article.